Article
Paroxysmal nocturnal haemoglobinuria: nature's gene therapy?
Molecular pathology : MP - 1 Jun 2002
Johnson R J, Hillmen P
Abstract excerpt
The development of paroxysmal nocturnal haemoglobinuria (PNH) requires two coincident factors: somatic mutation of the PIG-A gene in one or more haemopoietic stem cells and an abnormal, hypoplastic bone marrow environment. When both of these conditions are met, the fledgling PNH clone may flourish. This review will discuss the pathophysiology of this disease, which has recently been elucidated in some detail.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
